Persistent Corneal Epithelial Defect Clinical Trial
Official title:
Study of DE-105 Ophthalmic Solution in Patients With Persistent Corneal Epithelial Defect
Safety and efficacy of DE-105 ophthalmic solution in patients with persistent corneal epithelial defect will be evaluated. Dose-dependent efficacy will be evaluated as well.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03687632 -
ST266 Eye Drops for the Treatment of Persistent Corneal Epithelial Defects
|
Phase 2 | |
Recruiting |
NCT05966493 -
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
|
Phase 2/Phase 3 | |
Completed |
NCT05436288 -
A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial Defects
|
Phase 2 | |
Recruiting |
NCT05727878 -
Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
|
Phase 2 | |
Completed |
NCT02979912 -
Autologous Platelet Lysate in Corneal Epithelial Defects
|
Phase 1/Phase 2 | |
Terminated |
NCT05066698 -
ST266 Eyedrops for the Treatment of Persistent Corneal Epithelial Defects
|
Phase 2 | |
Withdrawn |
NCT05172349 -
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers
|
Phase 2 |